Newron announces half-year 2020 results

Newron Pharmaceuticals provides clinical and business update

Newron Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference

Newron Reports Top-Line Results from its STARS Study Evaluating Sarizotan in Patients with Rett Syndrome

Newron Acknowledges Definitive Agreement Between US WorldMeds and Supernus Pharmaceuticals Regarding XADAGO® (safinamide)

Newron Receives Third Tranche from Financing Agreement with European Investment Bank (EIB)

Newron AGM Result and Clinical and Business Update

Newron updates on STARS study FDA interaction

Newron announces 2019 financial results and provides outlook for 2020

Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

Pagination